The Dow Chemical Company

The Dow Chemical — FY2008 Earnings Presentation

35 slides from The Dow Chemical's earnings presentation, Feb 3, 2009

  1. Slide 1: 4Q & Full-Year 2008 Earnings Conference Call

    Slide 1: 4Q & Full-Year 2008 Earnings Conference Call

    The Dow Chemical Company 4Q & Full-Year 2008 Earnings Conference Call February 3, 2009 4Q08 Earnings Conference Call

  2. Slide 2: SEC Disclosure Rules

    Slide 2: SEC Disclosure Rules

    SEC Disclosure Rules Some of our comments today may include statements about our expectations for the future. Those expectations involve risks and uncertainties. Dow cannot guarantee the accuracy of any forecasts or estimates, and we do not plan to update any forward-looking statements if our expect

  3. Slide 3: Agenda

    Slide 3: Agenda

    Agenda ƒ 4Q08 Financial Performance ƒ Review of 2008 ̶ Financial performance ̶ Management interventions ƒ Looking Forward ̶ 2009 Outlook ̶ Strategy update ̶ Action plans 4Q08 Earnings Conference Call – Page 3

  4. Slide 4: 4Q08 Financial Highlights

    Slide 4: 4Q08 Financial Highlights

    4Q08 Financial Highlights ƒ 4Q08 sales were $10.9 billion, down 23% vs. 4Q07 ̶ Demand destruction impacting all geographies and operating segments ̶ Volume declined 17% vs. 4Q07 ̶ Price down 6% vs. 4Q07 ƒ Pricing in all Performance segments increased; double-digit decline in combined Basics pricing

  5. Slide 5: Performance Plastics

    Slide 5: Performance Plastics

    Performance Plastics Dollars in millions 4Q08 4Q07 Specialty Tech. Licensing & Dow Plastics & C atalyst Automotive Dow Building Sales $3,160 $3,968 Elastomers Solutions Price up 1%; Volume down 21% EBIT $(479) $158 Sales Certain items* included in EBIT $(333) $(184) Equity earnings (losses) included

  6. Slide 6: Performance Chemicals

    Slide 6: Performance Chemicals

    Performance Chemicals Dollars in millions 4Q08 4Q07 Designed Polymers Sales $1,968 $2,126 Specialty C hemicals Price up 9%; Volume down 16% EBIT $174 $124 Sales Certain items* included in EBIT $(25) $(83) Equity earnings included in EBIT $86 $83 Dow Latex * See Appendix for Supplemental Information

  7. Slide 7: Agricultural Sciences

    Slide 7: Agricultural Sciences

    Agricultural Sciences Dollars in millions 4Q08 4Q07 Seeds & Sales $885 $864 Traits Price up 6%; Volume down 4% EBIT $34 $(38) Sales Certain items* included in EBIT $(20) $(77) Equity earnings included in EBIT - $3 Ag C hem * See Appendix for Supplemental Information regarding certain items. 4Q08 Tre

  8. Slide 8: Basic Plastics

    Slide 8: Basic Plastics

    Basic Plastics Dollars in millions 4Q08 4Q07 Polystyrene Sales $2,167 $3,488 Polypropylene Price down 15%; Volume down 23% EBIT $(315) $394 Sales Certain items* included in EBIT $(181) $(88) Equity earnings (losses) included in EBIT $(54) $35 Polyethylene * See Appendix for Supplemental Information

  9. Slide 9: Basic Chemicals

    Slide 9: Basic Chemicals

    Basic Chemicals Dollars in millions 4Q08 4Q07 EO/EG Sales $992 $1,630 Price down 6%; Volume down 33% EBIT $(237) $309 Sales Certain items* included in EBIT $(118) $(7) Equity earnings (losses) included in EBIT $(20) $135 C ore * See Appendix for Supplemental Information regarding certain items. C he

  10. Slide 10: 4Q08 Financial Performance

    Slide 10: 4Q08 Financial Performance

    4Q08 Financial Performance Dollars in millions (except per share amounts) 4Q08 4Q07 Change Sales $10,899 $14,227 (23)% Price (6)% Volume (17)% Purchased feedstock & energy costs (23)% Equity earnings (losses) $(4) $294 (101)% Earnings (Loss) per share $(1.68) $0.49 (443)% Earnings (Loss) per share e

  11. Slide 11: 4Q08 Loss Per Share Reconciliation

    Slide 11: 4Q08 Loss Per Share Reconciliation

    4Q08 Loss Per Share Reconciliation Reported loss per share $(1.68) Goodwill impairment losses 0.25 Restructuring charges 0.68 Impact of Hurricanes Gustav and Ike 0.03 K-Dow related expenses 0.05 Purchased in-process R&D related to acquisitions 0.02 ROH acquisition-related expenses 0.03 Loss per shar

  12. Slide 12: Agenda

    Slide 12: Agenda

    Agenda ƒ 4Q08 Financial Performance ƒ Review of 2008 ̶ Financial performance ̶ Management interventions ƒ Looking Forward ̶ 2009 Outlook ̶ Strategy update ̶ Action plans 4Q08 Earnings Conference Call – Page 12

  13. Slide 13: Key Takeaways

    Slide 13: Key Takeaways

    Key Takeaways ƒ Financial results very disappointing ƒ Management interventions generated strong cash flow in a difficult environment ƒ Action plans are in place to address a challenging 2009 ƒ Strategy set-back temporary ƒ Committed to maintaining an investment grade rating 4Q08 Earnings Conference

  14. Slide 14: 2008 Full-Year Financial Performance

    Slide 14: 2008 Full-Year Financial Performance

    2008 Full-Year Financial Performance Dollars in millions (except per share amounts) 2008 2007 Change Sales $57,514 $53,513 7% Price 12% Volume (5)% Purchased feedstock & energy costs 28% Equity earnings $787 $1,122 (30)% Earnings per share $0.62 $2.99 (79)% Earnings per share excluding certain items

  15. Slide 15: Management Interventions

    Slide 15: Management Interventions

    Management Interventions ƒ Mid-Year: Two company-wide price increases to combat rising feedstock and energy costs ƒ October: Commitments to preserve cash and control costs in 4Q08 ƒ December: Aggressive actions in response to deteriorating economic environment ̶ Announced 11% workforce reduction ̶ S

  16. Slide 16: 4Q08 Financial Impact of Interventions

    Slide 16: 4Q08 Financial Impact of Interventions

    4Q08 Financial Impact of Interventions ƒ Exceeded Oct 2008 commitments to preserve cash ̶ Cut discretionary spending by more than $225 million ̶ Reduced volume of inventory by almost $900 million ƒ 4Q08 free cash flow* of $1.2 billion ƒ Ended the year in a position of financial strength ̶ $2.8 billi

  17. Slide 17: Agenda

    Slide 17: Agenda

    Agenda ƒ 4Q08 Financial Performance ƒ Review of 2008 ̶ Financial performance ̶ Management interventions ƒ Looking Forward ̶ 2009 Outlook ̶ Strategy update ̶ Action plans 4Q08 Earnings Conference Call – Page 17

  18. Slide 18: 2009 Outlook

    Slide 18: 2009 Outlook

    2009 Outlook ƒ Expect late-2008 demand levels to continue ̶ Value chains will remain in run-for-cash mode ƒ Expect a few bright spots in the market ̶ Agriculture fundamentals remain solid ̶ Rising global demand for clean water ̶ Higher energy efficiency standards ̶ Infrastructure projects play to Do

  19. Slide 19: Dow Response to Economic Realities

    Slide 19: Dow Response to Economic Realities

    Dow Response to Economic Realities ƒ Focus on financial discipline and cash preservation ƒ Protect the balance sheet ƒ Retain financial flexibility ƒ Maintain strategic direction 4Q08 Earnings Conference Call – Page 19

  20. Slide 20: K-Dow Update

    Slide 20: K-Dow Update

    K-Dow Update ƒ Disappointed by PIC’s breach of the Joint Venture Formation Agreement (JVFA) ƒ Actively pursuing legal options to enforce our rights and remedies ̶ Pursuing arbitration per the JVFA ̶ Lawsuit filed in early January ƒ Temporary strategic setback 4Q08 Earnings Conference Call – Page 20

  21. Slide 21: Rohm and Haas Update

    Slide 21: Rohm and Haas Update

    Rohm and Haas Update ƒ ROH transaction remains consistent with strategy ƒ Economic and chemical industry realities have changed dramatically ƒ Closing now creates unacceptable uncertainties for the combined entity ƒ Dow’s response to ROH lawsuit filed this morning ƒ Continue to search for business s

  22. Slide 22: Differences Between PIC and Dow Responses

    Slide 22: Differences Between PIC and Dow Responses

    Differences Between PIC and Dow Responses K-Dow Transaction ROH Transaction ƒ Political pressure improperly ƒ Combining enterprises at influenced a commercial this time would not be decision prudent ƒ Commercial conditions were ƒ Dow has asked for more changed to reflect economic time given economic

  23. Slide 23: Summary: Elements of Success Are in Place

    Slide 23: Summary: Elements of Success Are in Place

    Summary: Elements of Success Are in Place ƒ Dow remains a strong company ƒ Aggressive action plans in place ̶ Significant reduction in 2009 capital spending to $1.1 billion from $2.3 billion ̶ Accelerating restructuring announced in Dec 2008 New Targets Dec 2008 Announcement Dollars in millions Run-

  24. Slide 24: Appendix

    Slide 24: Appendix

    Appendix 4Q08 Earnings Conference Call

  25. Slide 25: Reconciliation of Non-GAAP Financial Measure

    Slide 25: Reconciliation of Non-GAAP Financial Measure

    Reconciliation of Non-GAAP Financial Measure Three Months Ended Dollars in millions 12/31/08 12/31/07 EBIT $(1,422) $602 + Interest income 14 29 - Interest expense and amortization of debt discount 192 161 - Credit for income taxes (60) (27) - Minority interests’ share in income 12 25 Net Income (Lo

  26. Slide 26: Reconciliation of Non-GAAP Financial Measure

    Slide 26: Reconciliation of Non-GAAP Financial Measure

    Reconciliation of Non-GAAP Financial Measure Full-Year Ended Dollars in millions 12/31/08 12/31/07 EBIT $1,883 $4,683 + Interest income 86 130 - Interest expense and amortization of debt discount 648 584 - Provision for income taxes 667 1,244 - Minority interests’ share in income 75 98 Net Income Av

  27. Slide 27: Supplemental Information

    Slide 27: Supplemental Information

    Supplemental Information Certain items affecting results - Fourth Quarters of 2008 and 2007 Results for the fourth quarter of 2008 were negatively impacted by the following items: ƒ Pretax costs totaling $54 million related to Hurricanes Gustav and Ike, which hit the U.S. Gulf Coast in the third qua

  28. Slide 28: Supplemental Information

    Slide 28: Supplemental Information

    Supplemental Information Certain items affecting results - Years Ending December 31, 2008 and 2007 In addition to the items described on the previous page for the fourth quarter of 2008, earnings for 2008 were unfavorably impacted by the following third quarter items: ƒ Pretax costs totaling $127 mi

  29. Slide 29: Supplemental Information

    Slide 29: Supplemental Information

    Supplemental Information Certain items affecting results Dollars in millions (except per share amounts) Pretax Impact on Impact Impact (1) Net Income (2) on EPS (3) Three Months Ended Three Months Ended Three Months Ended 12/31/08 12/31/07 12/31/08 12/31/07 12/31/08 12/31/07 Goodwill impairment loss

  30. Slide 30: Supplemental Information

    Slide 30: Supplemental Information

    Supplemental Information Certain items affecting results Dollars in millions (except per share amounts) Pretax Impact on Impact Impact (1) Net Income (2) on EPS (3) Full-Year Ended Full-Year Ended Full-Year Ended 12/31/08 12/31/07 12/31/08 12/31/07 12/31/08 12/31/07 Goodwill impairment losses $(239)

  31. Slide 31: Certain Items Affecting Results

    Slide 31: Certain Items Affecting Results

    Certain Items Affecting Results Certain items reducing EBIT by Operating Segment Dollars in millions Three Months Ended Full-Year Ended 12/31/08 12/31/07 12/31/08 12/31/07 Performance Plastics $(333) $(184) $(368) $(180) Performance Chemicals (25) (83) (39) (92) Agricultural Sciences (20) (77) (49)

  32. Slide 32: 4Q08 and Full-Year 2008 EPS Reconciliation

    Slide 32: 4Q08 and Full-Year 2008 EPS Reconciliation

    4Q08 and Full-Year 2008 EPS Reconciliation 4Q08 2008 Reported earnings (loss) per share $(1.68) $0.62 Goodwill impairment losses 0.25 0.25 Restructuring charges 0.68 0.68 Impact of Hurricanes Gustav and Ike 0.03 0.12 K-Dow related expenses 0.05 0.05 Purchased in-process R&D related to acquisitions 0

  33. Slide 33: Principal Joint Ventures

    Slide 33: Principal Joint Ventures

    Principal Joint Ventures Although Dow participates in many joint ventures, the most significant joint ventures from a financial perspective are: Americas Styrenics LLC* Compañía MEGA S.A. Dow Corning Corporation EQUATE Petrochemical Company K.S.C. Equipolymers MEGlobal The OPTIMAL Group of Companies

  34. Slide 34: Preliminary Results for Principal Joint Ventures

    Slide 34: Preliminary Results for Principal Joint Ventures

    Preliminary Results for Principal Joint Ventures Principal Joint Ventures - Total Dow Proportionate Share Dollars in millions (unaudited) 4Q08 4Q07 Dollars in millions (unaudited) 4Q08 4Q07 Sales $2,894 $3,805 Sales $1,383 $1,790 Adjusted Sales* $2,360 $3,011 Adjusted Sales* $1,150 $1,438 EBIT** $27

  35. Slide 35: Preliminary Results for Principal Joint Ventures

    Slide 35: Preliminary Results for Principal Joint Ventures

    Preliminary Results for Principal Joint Ventures Principal Joint Ventures - Total Dow Proportionate Share Dollars in millions (unaudited) YTD08 YTD07 Dollars in millions (unaudited) YTD08 YTD07 Sales $15,488 $13,884 Sales $7,304 $6,532 Adjusted Sales* $12,098 $10,837 Adjusted Sales* $5,831 $5,197 EB

Source: Internet Archive copy of dow.com

More decks from The Dow Chemical Company